This paper reports our experience in monitoring gentamicin therapy during the treatment of 68 episodes of serious Gramnegative sepsis in 65 hospital patients. Most of the patients had major underlying disease. Of those who were adequately treated (peak serum concentrations of 5 ,ug/ml or more in 72 hours for septicaemia, urinary tract infection, and wound infection; and 8 ,ug/ml or more at some time during the course of treatment for pneumonia) B4% (46 out of 55) were cured. These serum concentrations could be achieved only by starting with a regimen of 5 mg/kg/day in three divided doses in ali adult patients, subsequent dosage being determined by the results of rapid serum assay. The incidence of nephrotoxicity and symptomatic ototoxicity was no greater than in previous series. The main reason for assaying serum gentamicin is to ensure that an adequate dosage is achieved as soon as possible. In patients with impaired renal function or receiving prolonged high dosage assays also serve to guard against an excessive accumulation of gentamicin and an increased risk of toxicity.
Introduction
Gentamicin is widely considered to be the first-choice antibiotic for serious Gram-negative sepsis (Martin et al., 1969; Marsden and Hyde, 1970; Darrell and Neale, 1972) . Its use has been associated with ototoxicity in 2 to 3 % of patients (Jackson and Arcieri, 1971) , while nephrotoxicity has also been reported (Hewitt, 1971; Wilfert et al., 1971) . At first toxicity was thought to be related to serum concentration and therefore monitoring gentamicin therapy was considered essential, especially in patients with impaired renal function or undergoing dialysis. Rapid assay techniques now permit close monitoring of aminoglycoside therapy, allowing doseby-dose modification. We report an analysis of our experience treating 68 episodes of serious Gram-negative infection among 65 hospital patients, including a retrospective assessment of 8th cranial nerve function in 23 patients.
Materials and Methods

BACTERIOLOGICAL INVESTIGATIONS
Urine cultures were performed at 37'C on C.L.E.D. agar (Oxoid Limited) using a standard loop technique. Blood specimens were taken into tryptose soya broth (Oxoid) for aerobic culture and Brewer's thioglycollate medium (Oxoid) for anaerobic culture at 37°C. Sputum was digested with trypure-pancreatin mixture and cultured at 37'C on Columbia blood agar (Oxoid) and MacConkey agar (Oxoid) at dilutions of 1/2 and 1/10-4 (diluted in quarter-strength Ringer's solution). Wound swabs, aspira,tions of pus, and pleural fluid were cultured at 37'C aerobically and anaerobically (in hydrogen with 5% carbon dioxide) on Columbia agar and MacConkey agar. Organisms isolated by these methods were identified according to the criteria and techniques recommended by Cowan and Steel (1966) . Antibiotic sensitivity tests for Gram-negative organisms were performed at 37'C on D.S.T. agar (Oxoid) with 10% lysed horse blood using Oxoid antibiotics disks. Eschericia coli (N.C.T.C. 10418) and Pseudomonas aeruginosa (N.C.T.C. 10662) were used daily as controls. All Gram-negative isolates were sensitive to gentamicin by this method. The minimum inhibitory concentration of particular antibiotics was determined according to the methods described by Cruickshank (1965) .
BASIS OF MONITORING THERAPY
The advice on therapy given by medical microbiologists was based on the following observations. Pharmacological studies in man indicate that "the concentration of gentamicin in the blood is representative of the tissue level throughout the body and this value may be used for therapeutic purposes" (Chisholm et al., 1968) . Peak serum concentrations after intramuscular injection occur within 30-120 minutes, but the concentration in serum taken one hour after the injection is at least 70% of ithe peak concentration after any single dose (Black et al., 1963) . In-vitro studies showed ithat the minimum inhibitory concentration of gentamicin for all the aerobic Gram-negative isolates from clinically-significant sepsis was 2 ,ug/ml or less. At first, therefore, adequate gentamicin therapy was considered to be that dosage which gave a serum concentration of at least 5 ,ug/ml one hour after an intramuscular injection or 15 minutes after an intravenous injection of the antibiotic (hereafter referred to as peak concentration). In the treatment of serious or life-threatening sepsis it seemed logical to try to achieve such concentrations as early as possible in a course of gentamicin. The urease method (Noone et al., 1972) (1) Pr. mirabilis (1 mixed) tor had evidence of deep tissue involvement. Of five patients with abscesses four were drained and were cured and one was not drained and died. Of four patients with peritonitis the two aged 60 years or over with neoplastic or necrotic areas of bowel died and the two who survived were aged 34 and 20 years and had benign disease of ithe bowel. Nevertheless, these latter patients were also noteworthy because of the very high serum concentrations of gentamicin achieved. One with confirmed E. coli septicaemia had peak serum concentrations of between 12 and 18 ug/ml on each of the first five days of treatment. The other, through renal insufficiency coincident with the course of gentamicin, had peak senr concentrations of 12 to 30 ,ug/ml and itrough concentrations of up to 15 jug/ml. No evidence of toxicity was seen in either patient.
GRAM-NEGATIVE PNEUMONIA All 29 episodes of pneumonia (table III) were characterized by the association of clinical signs and symptoms (pyrexia, purulent sputum production, dyspnoea, and chest pain) with radiological signs of pneumonia. Gram-negative organisms were considered to be the causative pathogens since they were isolated in heavy growth (that is, more than 101 organisms/ml) by dilution technique from fresh sputum aspirated from the lower respiratory tract (11 cases), or from two (three cases) or more than two (13 cases) freshly-taken purulent specimens of sputum. In 25 episodes a single organism was isolated in pure growth and in four a mixture of two Gram-negative organisms was found. The same organisms were also isolated from blood cultures (three cases), pleural aspirate (three cases), and swabs of lung pus taken at necropsy (one case). Since 24 of the episodes of pneumonia occurred during or immediately after the administration of ampicillin (and of cloxacillin also in 12) it is most unlikely that the clinical signs and symptoms were due to Haemophilus species or Streptococcus pneumoniae, the isolation of which was masked by overgrowth with "contaminating" coliforms or Pseudomonas. Moreover, 11 of the 12 episodes treated with gentamicin alone were cured, whereas of the 16 episodes treated with gentamicin in combination with other antimicrobial drugs (carbenicillin in three, ampicillin in two, ampicillin and cloxacillin in six, cephalosporin in four, and benzylpenicillin in one) only eight were cured. Nevertheless, both patients who received adequate doses of antibiotics other than gentamicin to which the isolated Gram-negative organisms were known to be sensitive were cured. Thus there 479 is very good direct and indirect evidence of the aetiological nature of the Gram-negative isolates in these cases of pneumonia. In those cured the patients were alive and well six months to two years later except one who died of an unrelated cerebrovascular accident six months later.
There is no significant difference between the episodes of cured and uncured pneumonia in terms of age, underlying disease,-or organisms isolated. Nevertheless, the monitoring of serum gentamicin concentrations in these cases indicated that a peak serum concentration of 8 ,ug/ml (rather than the anticipated 5 jtg/ml) or more was significant. In two patients assays were not done and in two others with irreversible brain damage the courses were discontinued. Peak serum concentrations of 8 ,ug/ml or more were achieved during the treatment of 18 of the remaining 25 episodes of pneumonia, and of these 16 (89%) were cured. In one case the patient died after seven days treatment, a concentration of 8 ,g/ml or greater having been achieved only on the last day, and in another the patient was discharged clinically improved but with her sputum still positive for the organism originally isolated. Of the seven episodes in which a peak serum concentration of 8 ,g/ml or more was not achieved only three (43%) were cured. In two of these only a single assay was done, giving values of 5-0 and 7-0 ,tg/ml respectively, and in the third three were three peak values between 5 5 and 7 0 ,ug/ml. In three cases clinical improvement took place only when the dose was increased on the basis of results of assays, and in one case on low dose therapy improvement occurred only when acute renal failure supervened and high serum concentrations developed.
GRAM-NEGATIVE SEPTICAEMIA
A clinical diagnosis of Gram-negative septicaemia was confirmed in 15 episodes of infection by growing the same organism from at least two blood cultures (in one case from the transfusion pack). Eleven out of the 15 episodes were associated with the episodes of urinary tract infection, wound infeotion, or pneumomna reported above. They were all treated with gentamicin (table IV) In only two cases were the patients sufficiently improved clinically when the sensitivities of the infecting organism were known for gentamicin to be discontinued and therapy with ampicillin and co-trimoxazole substituted. Of the five patients treated with a combination of gentamicin and another antibiotic to which -the infecting organism was also sensitive three survived and two died. Overall, 10 patients recovered and five died either directly from septicaemia or from other causes with septicaemia as a contributory factor. In all 10 patients who were cured of septicaemia a level of 5 ug/ml was recorded during the first three days of treatment. Of the five patients who died only one had such a level recorded in the first three days of treatment, three never achieved such a level, and one only on the tenth day of treatment.
Side (table V) . The most striking predisposing factor, espeially for pneumonia, seems to be previous treatment with broad.4spectrum anti(biotics, particularly ampicillin. Such antibiotics were most often given for non-specific broad spectrum prophylaxis in cases of major surgery, cardiac failure, respiratory distress, radiotherapy, etc. This practice is of very doubtful benefit, and perhaps Gram-negative pneumonia and sepsis generally may be better prevented by withholding antibiotics except when specifically indicated (Price and Sleigh, 1970) . Gentamicin is of proved value in urinary tract infections. Concentrations of the drug in the urine are about 5 to 10 times the peak serum concentrations (Riff and Jackson, 1971 ). Attention to high serum concentrations may not be considered necessary. Nevertheless, in this series two of the "failures" exemplify two dangers of underdosage-emergence of antibiotic resistance in the infecting organism, and failure of therapy leading to complications and death of the patient. Of the 18 episodes in which a peak serum concentration of 5 ,ug/ml or greater was achieved in the first three days of treatment the cure rate was 94%. The efficacy of systemicallyadministered gentamicin in the treatment of Gram-negative pneumonia has been much less certain. For example. Gatmaitan et al. (1970) reported favourable results, whereas Klastersky et al. (1972) reported only two cures in eight cases treated with systemic genitamicin. Nevertheless, in the present series, where strict criteria were used for determining diagnosis and cure, a cure rate of 89 %was achieved in 18 patients in whom peak serum concentrations of 8 ,ug/ml or more were obtained. Possibly the relatively poor penetration of the drug into infected lung tissue explains the need for higher peak serum concentrations in patients witth pneumonia. Ten out of 11 (90%) of the patients with episodes of Gram-negative septicaemia in whom peak serum concentrations of 5 p,g/ml or more were achieved within the first three days of treatment were cured. With wound infections the ou)tcome was closely related to complications and the general condition of the patient, but notably two young patients who recovered completely from faecal peritonitis and Gramnegative shock had consistently the highest serum concentrations recorded in all 65 patients.
The overall cure rate in adequately treated patients was 84% (table V) . Larger daily doses than 'those conventionally recommended are necessary for adequate therapy. In adults 5 mg/kg/day in three divided doses is the minimum starting treatment regardless of renal function. Serum concentrations should be monitored ito ensure adequate therapy, and subsequent dosage, depending on individual response, may have to be reduced in patients with impaired renal function or increased even further in patients with a "damped response" (Riff and Jackson, 1971 
